| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/CBT.20080 |
| P953 | full work available online at | https://www.tandfonline.com/doi/pdf/10.4161/cbt.20080?needAccess=true |
| P698 | PubMed publication ID | 22555806 |
| P2093 | author name string | Bahija Jallal | |
| Zhan Xiao | |||
| Rosa Carrasco | |||
| Steve Coats | |||
| Darrin Sabol | |||
| Krista Kinneer | |||
| David A. Tice | |||
| P2860 | cites work | Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation | Q22011187 |
| Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells | Q24301457 | ||
| EphB4 expression and biological significance in prostate cancer | Q24304334 | ||
| Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt | Q24318755 | ||
| Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling | Q24532278 | ||
| Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development | Q28145776 | ||
| Bidirectional Eph-ephrin signaling during axon guidance | Q28297294 | ||
| Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites | Q28609103 | ||
| Eph-ephrin bidirectional signaling in physiology and disease | Q29617975 | ||
| Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction | Q31813080 | ||
| Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia | Q33482013 | ||
| Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia | Q33754623 | ||
| Eph receptors and ephrins in cancer: bidirectional signalling and beyond | Q34021365 | ||
| Inhibition of tumor growth and angiogenesis by soluble EphB4. | Q34770033 | ||
| Receptor tyrosine kinase EphB4 is a survival factor in breast cancer | Q35221906 | ||
| The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth | Q35849505 | ||
| EphB/EphrinB receptors and Wnt signaling in colorectal cancer | Q36362266 | ||
| The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome | Q36610209 | ||
| Paradoxes of the EphB4 receptor in cancer | Q36812751 | ||
| Cell-cell signaling via Eph receptors and ephrins | Q36967529 | ||
| Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression | Q39861032 | ||
| EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. | Q40074110 | ||
| EPHB4 and survival of colorectal cancer patients. | Q40230554 | ||
| The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway | Q40252238 | ||
| Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes | Q40359711 | ||
| EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase | Q40392006 | ||
| EphB receptor activity suppresses colorectal cancer progression | Q40405920 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | MAP kinase signaling system | Q71130435 |
| P304 | page(s) | 630-637 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target | |
| P478 | volume | 13 |
| Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
| Q41828383 | Anti-tumour effects of antibodies targeting the extracellular cysteine-rich region of the receptor tyrosine kinase EphB4. |
| Q57176106 | BCL2 inhibitor ABT-199 and JNK inhibitor SP600125 exhibit synergistic cytotoxicity against imatinib-resistant Ph+ ALL cells |
| Q41821364 | Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4 |
| Q55286883 | Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers. |
| Q38109928 | Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions |
| Q90883711 | EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells |
| Q37122330 | Eph receptor signaling and ephrins |
| Q38209232 | Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics |
| Q55512730 | Eph/Ephrin-mediated stimulation of human bone marrow mesenchymal stromal cells correlates with changes in cell adherence and increased cell death. |
| Q37448572 | EphB4 tyrosine kinase stimulation inhibits growth of MDA-MB-231 breast cancer cells in a dose and time dependent manner. |
| Q49709391 | EphB4: A promising target for upper aerodigestive malignancies |
| Q35536905 | Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro. |
| Q38842539 | EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease. |
| Q27852191 | Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab. |
| Q42352727 | Improving the Outcome of Vein Grafts: Should Vascular Surgeons Turn Veins into Arteries? |
| Q37643632 | Membrane-mediated regulation of vascular identity. |
| Q52595509 | Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. |
| Q89636636 | Pumping the brakes on RAS - negative regulators and death effectors of RAS |
| Q90744589 | Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation |
| Q89721920 | The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2 |
| Q38174793 | Therapeutic targeting of EPH receptors and their ligands |
Search more.